Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vagina
Piver, M.S.; Barlow, J.J.; Dunbar, J.
Cancer Treatment Reports 64(4-5): 549-551
1980
ISSN/ISBN: 0361-5960 PMID: 7000344 Document Number: 166529
Thirty-six evaluable patients with carcinoma of the uterine cervix or vagina not amenable to surgery or radiation therapy were treated with doxorubicin, cyclophosphamide, and 5-fluorouracil; 16.5% of the patients responded, with 2.7% having a complete response. Only four (11.17%) of the 36 patients are alive, all with persistent malignancy, and none of the responders are alive. Because of the low response and survival rates, this combination is not recommended for women with recurrent cervical or vaginal carcinoma.
Document emailed within 1 workday
Related Documents
Yamashita, K.; Mitani, K.; Morishita, Y.; Inoue, K. 1989: The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Part 1): 767-773West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Noller, K.L.; Decker, D.G.; Dockerty, M.B.; Lanier, A.P.; Smith, R.A.; Symmonds, R.E. 1974: Mesonephric (clear cell) carcinoma of the vagina and cervix. A retrospective analysis Obstetrics and Gynecology 43(5): 640-644
Murata, K.; Shiraki, K.; Kawakita, T.; Yamamoto, N.; Okano, H.; Nakamura, M.; Sakai, T.; Deguchi, M.; Ohmori, S.; Nakano, T. 2003: Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Research 23(2c): 1719-1722
Brugarolas, A.; Rivas, A.; Lacave, A.J.; Gonzalez-Palacois, F.; Froufe, A. 1975: 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study Cancer ChemoTherapy Reports 59(5): 1025-1026
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Alberts, D.S.; Ignoffo, R. 1978: Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix Cancer Treatment Reports 62(1): 143-144
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G. 1979: Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles Minerva Ginecologica 31(7-8): 563-568
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Logothetis, C.J.; Samuels, M.L.; Selig, D.E.; Wallace, S.; Johnson, D.E. 1985: Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors Cancer Treatment Reports 69(1): 33-38
Takada, T.; Nimura, Y.; Katoh, H.; Nagakawa, T.; Nakayama, T.; Matsushiro, T.; Amano, H.; Wada, K. 1998: Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial Hepato-Gastroenterology 45(24): 2020-2026
Trifard, F.; Chrétien, Y.; Vallantin, X.; Collet, C.; Lachand, A.T.; Dufour, B. 1988: [Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients Annales d'Urologie 22(3): 216-219
Pectasides, D.; Tsavdaridis, D.; Aggouridaki, C.; Tsavdaridou, V.; Visvikis, A.; Tsatalas, K.; Fountzilas, G. 1999: Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage Ii breast cancer patients Anticancer Research 19(4c): 3521-3526
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Rahman, Z.; Champlin, R.; Rondon, G.; Frye, D.; Valero, V.; Mehra, R.; Hortobagyi, G. 1997: Phase I/Ii study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076
Berget, A. 1975: Epidemiologic characteristics in patients with epithelial dysplasi, carcinoma in situ, and invasive carcinoma of the uterine cervix. The population screening for cervical carcinoma in Maribo amt (county) 1967-1969 Danish Medical Bulletin 22(6): 252-259
Oellinger, J.J.; Michniewicz, K.; Blohmer, J.U.; Hosten, N.; Siewert, C.; Lichtenegger, W.; Felix, R. 1998: Cervix carcinoma: staging, therapy, after-care. Experiences with magnetic resonance tomography of cervix carcinoma based on recent literature 1993 to 1997 Zentralblatt für Gynakologie 120(8): 373-385